ProHealth me-cfs Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Chronic Pain, Loneliness, Depression and Suicide

Things to Do When You're Mostly Housebound

Is a Good Night's Sleep at the Top of Your Wishlist?

When Everybody has a Plan in Life Except You

The Restorative Power of Nature

A Holiday Gift Guide for People with ME/CFS and Fibromyalgia

Cellular Energy Production Takes Big Hit in Chronic Fatigue Syndrome (ME/CFS) Study

Norwegian Rituximab Chronic Fatigue Syndrome (ME/CFS) Trial Fails

VIDEO: Dear Healthy People: Identity Crisis

Horror to Hope: Grief to Action

 
Print Page
Email Article

ME/CFS associated with later life non-Hodgkin lymphoma: Medicare statistics

  [ 26 votes ]   [ 2 Comments ]
www.ProHealth.com • June 1, 2012


Article:
Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults 
– Source: Cancer, May 30, 2012

by Cindy M Chang, Joan L Warren, Eric A Engels

[Note: an OR (odds ratio) of 1.0 would signify no difference in average risk between CFS & non-CFS populations. An OR of 1.88, for example, would indicate an 88% greater average risk for the CFS population. OR of 1.51 would be 51% greater average risk, and so on.]

Abstract:
Summary: Using US linked registry data on 1.2 million cancer cases and 100,000 population-based controls, risk was evaluated for a wide range of cancer types following a diagnosis of chronic fatigue syndrome. A strongly significant elevated risk was found for non-Hodgkin lymphoma associated with chronic fatigue syndrome, and in particular, associations for 2 specified non-Hodgkin lymphoma subtypes (diffuse large B cell lymphoma and marginal zone lymphoma).

Background: The cause of chronic fatigue syndrome (CFS) is unknown but is thought to be associated with immune abnormalities or infection.

Because cancer can arise from similar conditions, associations between CFS and cancer were examined in a population-based case-control study among the US elderly.

Methods: Using linked Surveillance, Epidemiology, and End Results (SEER)-Medicare registry data, approximately 1.2 million cancer cases and 100,000 controls (age range, 66-99 years; 1992-2005) were evaluated.

CFS was identified in the period more than 1 year prior to selection, using linked Medicare claims. Unconditional logistic regression was used to estimate the odds ratios (ORs) comparing the CFS prevalence in cases and controls, adjusting for age, sex, and selection year. All statistical tests were 2-sided.

Results:

• CFS was present in 0.5% of cancer cases overall and 0.5% of controls [1 in 200 people in Medicare database].

• CFS was associated with an increased risk of non-Hodgkin lymphoma (NHL) (OR = 1.29, 95% confidence interval [CI] = 1.16-1.43, P = 1.7 × 10?6th).

• Among non-Hodgkin lymphoma subtypes, CFS was associated with diffuse large B cell lymphoma (OR = 1.34, 95% CI = 1.12-1.61), marginal zone lymphoma (OR = 1.88, 95% CI = 1.38-2.57), and B cell NHL not otherwise specified (OR = 1.51, 95% CI = 1.03-2.23).

CFS associations with non-Hodgkin lymphoma overall and NHL subtypes remained elevated after excluding patients with medical conditions related to CFS or non-Hodgkin lymphoma, such as autoimmune conditions.

CFS was also associated, although not after multiple comparison adjustment, with cancers of the pancreas (OR = 1.25, 95% CI = 1.07-1.47), kidney (OR = 1.27, 95% CI = 1.07-1.49), breast (OR = 0.85, 95% CI = 0.74-0.98), and oral cavity and pharynx (OR = 0.70, 95% CI = 0.49-1.00).

Conclusions: Chronic immune activation or an infection associated with CFS may play a role in explaining the increased risk of non-Hodgkin lymphoma.

Source: Cancer, May 30, 2012. DOI: 10.1002/cncr.27612, by Chang CM, Warren JL, Engels EA. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland; Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA. [Email: Eric A. Engels MD, MPH (engelse@exchange.nih.gov)] National Cancer Institute Senior Investigator Eric Engels, MD, MPH, specializes in study of immunosuppression, infection and inflammation in cancer; Cindy Chang, PhD, MPH, specializes in non-Hodgkin lymphoma research; and Joan L Warren, PhD, specializes in Medicare data analysis for cancer-related research.

The authors note: This study used the linked Surveillance, Epidemiology, and End Results (SEER)-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the Applied Research Program, National Cancer Institute; the Office of Research, Development, and Information, Centers for Medicare and Medicaid Services; Information Management Services, Inc.; and the SEER Program tumor registries in the creation of the SEER-Medicare database. We thank Winnie Ricker (Information Management Services, Rockville, MD) for assistance with database management.





Post a Comment

Featured Products From the ProHealth Store
Mitochondria Ignite™ with NT Factor® Hydroxocobalamin Extreme™ Energy NADH™ 12.5mg


Article Comments Post a Comment

Correlation strength
Posted by: blacksnake
Jun 4, 2012

Thank you for posting this article.

I suggest that the OR demonstrates "mild" or "moderate" association between CFS and NHL.

"Strong" is like smoking and lung cancer - OR of 11.
Reply Reply

What about younger patients?
Posted by: aryiella
Jun 23, 2012
This only looked at the correlation for ages 66-99. How can we know if the same increased risk applies to younger ages groups as well? I'm 37 and wondering how much I really need to worry about this right now.
Reply Reply
 
Optimized Curcumin Longvida with Omega-3

Featured Products

Hydroxocobalamin Extreme™ Hydroxocobalamin Extreme™
The B-12 Your Brain Needs for Detox & Sharpness
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
B-12 Extreme™ B-12 Extreme™
The Most Potent Vitamin B-12 on Earth
Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium

Natural Remedies

Stop Bacteria With Nature's Antibiotics Stop Bacteria With Nature's Antibiotics
Coping When Colds or Flu Catch Up with You Coping When Colds or Flu Catch Up with You
Carry a Massage Therapist in Your Pocket Carry a Massage Therapist in Your Pocket
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
The Surprising Benefits of Probiotics - What You Didn't Know The Surprising Benefits of Probiotics - What You Didn't Know

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map